Determination of force degradation and solution stability studies of (bortezomib) proteasome inhibitor by HPLC method

Journal Title: Indian Journal of Research in Pharmacy and Biotechnology - Year 2015, Vol 3, Issue 5

Abstract

A forced degradation study is an essential step in the design of a regulatory compliant stability program for both drug substances and products, and formalized as a regulatory requirement in ICH Guideline Q1A in 1993. In designing forced degradation studies of Bortezomib, remembered that more strenuous conditions than those used for accelerated studies (25°C/60% RH or 40°C/75% RH) are used. Investigation was performed in conditions acid like base hydrolysis, hydrolysis at various pH, thermal degradation, photolysis, and oxidation. Forced degradation is a degradation of new drug substance and drug product at conditions more severe than accelerated conditions. Solution stability showing that more than 98 % of the Bortezomib remained unchanged after storage at room temperature for 12 h, on the basis of comparison of peak areas with those obtained from a freshly prepared solution of Bortezomib (200 ppm). This research paper showing solution stability and forced degradation studies of Bortezomib substances and Bortezomib products by providing a strategy for conducting studies on degradation mechanisms.

Authors and Affiliations

Suresh Kumar Agrawal, Dr. R. P Singh, Dr. Ritu M. Gilhotra, Dr. S. K Singh, Dr. Devendra Singh Rathore

Keywords

Related Articles

DEVELOPMENT AND VALIDATION OF A SIMPLE AND RAPID RP- HPLC METHOD FOR THE DETERMINATION OF METRONIDAZOLE AND NORFLOXACIN IN COMBINED DOSAGE FORM

The present investigation describes about a simple, economic, selective, accurate, precise reverse phase high performance liquid chromatographic method for the simultaneous estimation of Metronidazole and Norfloxacin i...

Development and Validation of Related Substances Method for Febuxostat Tablets by RP-HPLC

The present paper describes about highly sensitive, linear, precise, rugged, accurate and robust RP-HPLC method for determination of related substances present in Febuxostat tablets. Chromatographic separation with sep...

Evaluation of Nootropic activity of Two Marketed Drugs of Bacopa monnieri In Scopolamine Induced Amnesic Models

Evaluation of Nootropic activity of Two Marketed Drugs of Bacopa Monnieri In Scopolamine Induced Amnesic Models. The Learning and memory parameters were evaluated by using Morris water maze and Passive avoidance model...

Anti-osteoporotic effect of Urtica dioica on ovariectomised rat

This study was undertaken to check the anti-osteoporotic activity of Urtica dioica on ovariectomised (OVX) rats. Bilateral ovariectomy was performed in rats under aseptic condition and ether anaesthesia. Healthy albino...

A new method development and validation for the simultaneous estimation of Zolpidium and Melatonin by using RP HPLC in a bulk and pharmaceutical dosage forms

A simple and selective Liquid Chromatography method was described for the determination of Melatonin and Zolpidem tartarate in tablet dosage forms. Chromatographic separation was achieved on a c18 column using mobile p...

Download PDF file
  • EP ID EP33333
  • DOI -
  • Views 260
  • Downloads 0

How To Cite

Suresh Kumar Agrawal, Dr. R. P Singh, Dr. Ritu M. Gilhotra, Dr. S. K Singh, Dr. Devendra Singh Rathore (2015). Determination of force degradation and solution stability studies of (bortezomib) proteasome inhibitor by HPLC method. Indian Journal of Research in Pharmacy and Biotechnology, 3(5), -. https://europub.co.uk/articles/-A-33333